XRP Just Became a MUCH BIGGER Problem

XRP is getting harder to dismiss. We’re breaking down why the story around XRP is getting much bigger than payments alone. The onchain economy is accelerating. Institutional settlement is moving toward 24/7. Cross-border costs are collapsing. Credit and lending infrastructure is being built directly into the XRP Ledger. Batch transactions are getting security audits. Developers are being pushed toward XLS-65 and XLS-66. And the Bitwise XRP ETF has now crossed $500 million in assets under management. This is no longer one isolated XRP headline. The infrastructure is stacking. Payments. Tokenization. Trading. Lending. Credit. Institutional access. And the bigger that stack gets, the harder XRP becomes to ignore. Chip and Jeff break down: • Why Uphold says the new financial system is moving onchain • Why XRP and XRPL keep showing up in the institutional conversation • The new XRPL credit and lending rail • XLS-65 and XLS-66 • The upcoming XRPL lending hackathon • The latest Batch Transactions security audit • The Bitwise XRP ETF crossing $500M AUM • What all of this could mean for XRP adoption • Plus tonight’s biggest geopolitical stories from the U.S., Canada, the U.K. and beyond This one goes much deeper than price. The question is no longer whether XRP has a use case. The question is how much of the next financial system gets built around the rails XRP was designed to use. 🔥 SUPPORT ON THE CHAIN 🔥 ☕ BADASSERY COFFEE https://badasserycoffee.com 🪙 OTC MINT https://otc.one/mint 👕 OTC MERCH https://onthechain.shop 📩 SUBSCRIBE TO OTC https://onthechain.io/subscribe/ ☕ BUY US A COFFEE https://buymeacoffee.com/onthechain 🌐 ON THE CHAIN https://onthechain.io 🎙️ OTC PODCAST https://otc.one/podcast FOLLOW US ON X On The Chain: https://x.com/On_The_Chain Jeff: https://x.com/Jeff_OnTheChain Chip: https://x.com/stephenchip Please LIKE, SUBSCRIBE and hit the notification bell so you don’t miss the next live show. #XRP #XRPL #Ripple #Crypto ``` That **full Support On The Chain block** is the one I should be carrying into every OTC YouTube description.